Walter S. Speidl - Concepedia

Author

Walter S. Speidl

Also Known As

Hamlet Hayrapetyan, Johann Wojta, Kurt Huber, N. Oka, Ronak Delewi, W S Speidl, W SPEIDL, W Speidl, W. S. Speidl, W. Speidl

198

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Wilhelminen Hospital Ludwig Boltzmann Institute for Cardiovascular Research Ludwig Boltzmann Institute for Digital Health and Prevention University of Vienna

About

Walter S. Speidl is an author at Medical University of Vienna specializing in medicine, vascular biology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	37	1.8K
2	Cell Biology	9	9	397
3	Public Health	7	7	534
4	Health Sciences	2	2	82
5	Allergy	1	1	30

Walter S. Speidl

Publications

Citations

H-Index

Page 1

	Year	Citations
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons, The Lancet Family MedicineMetabolic SyndromeLipid DisorderCardiovascular DiseaseHealth Policy	2021	285
Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage Borja Ibáñez, S Prat, Walter S. Speidl, Circulation	2007	157
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo Alexander Niessner, Sabine Steiner, Walter S. Speidl, Atherosclerosis InflammationToll-like ReceptorsCytokineAutoimmune DiseaseMedicine	2006	151
Simvastatin Blunts Endotoxin-Induced Tissue Factor In Vivo Sabine Steiner, Walter S. Speidl, Johannes Pleiner, Circulation	2005	146
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis Walter S. Speidl, Markus Exner, Jasmin Amighi, European Heart Journal	2005	142
Rapid Change in Plaque Size, Composition, and Molecular Footprint After Recombinant Apolipoprotein A-IMilano (ETC-216) Administration Borja Ibáñez, Gemma Vilahur, Giovanni Cimmino, Journal of the American College of Cardiology InflammationVascular DiseaseRapid ChangeImmunologyPathology	2008	126
Neutrophil Extracellular Trap Degradation by Differently Polarized Macrophage Subsets Patrick Haider, Julia B. Kral‐Pointner, Julia Mayer, Arteriosclerosis Thrombosis and Vascular Biology	2020	110
Vascular Endothelial Growth Factor Is Induced by the Inflammatory Cytokines Interleukin-6 and Oncostatin M in Human Adipose Tissue In Vitro and in Murine Adipose Tissue In Vivo Christoph Kaun, Svitlana Demyanets, Stefan Pfaffenberger, Arteriosclerosis Thrombosis and Vascular Biology	2007	102
The complement component C5a is present in human coronary lesions <i>in vivo</i> and induces the expression of MMP‐1 and MMP‐9 in human macrophages <i>in vitro</i> Walter S. Speidl, Stefan P. Kasd, Randolph Hutter, The FASEB Journal	2010	95
Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome Svitlana Demyanets, Walter S. Speidl, Ioannis Tentzeris, PLoS ONE	2014	94

Page 1